Establishment and Evaluation of Exosomes-Related Gene Risk Model in Hepatocellular Carcinoma
Authors:
Open Access
- 5 July 2023
- journal article
- research article
- Published by Springer Nature in Biochemical Genetics
- Vol. 62 (2) , 698-717
Abstract
Hepatocellular carcinoma (HCC) is a challenging disease to evaluate in terms of prognosis, requiring close attention to the prognosis of HCC patients. Exosomes have been shown to play an important role in HCC development and have significant potential in managing HCC patient prognosis, as they are detectable in patients’ blood. By using small extracellular vesicular RNA, liquid biopsies can reflect the underlying physiological and pathological status of the originating cells, providing a valuable assessment of human health. No study has explored the diagnostic value of mRNA expression changes in exosomes for liver cancer. The present study investigated establishing a risk prognosis model based on mRNA expression levels in exosomes from blood samples of liver cancer patients and evaluated its diagnostic and prognostic value, providing new targets for liver cancer detection. We obtained mRNA data from HCC patients and normal controls from the TCGA and exoRBase 2.0 databases and established a risk prognostic assessment model using exosomes-related risk genes selected through prognostic analysis and Lasso Cox analysis. The patients were divided into high-risk and low-risk groups based on median risk score values to validate the independence and evaluability of the risk score. The clinical value of the model was further analyzed using a nomograph model, and the efficacy of immunotherapy and cell-origin types of prognostic risk genes were further assessed in the high- and low-risk groups by immune checkpoint and single-cell sequencing. A total of 44 genes were found to be significantly associated with the prognosis of HCC patients. From this group, we selected six genes (CLEC3B, CYP2C9, GNA14, NQO1, NT5DC2, and S100A9) as exosomal risk genes and used them as a basis for the risk prognosis model. The clinical information of HCC patients from the TCGA and ICGC databases demonstrated that the risk prognostic score of the model established in this study was an independent prognostic factor with good robustness. When pathological stage and risk prognostic score were incorporated into the model to predict clinical outcomes, the nomograph model had the best clinical benefit. Furthermore, immune checkpoint assays and single-cell sequencing analysis suggested that exosomal risk genes were derived from different cell types and that immunotherapy in the high-risk groups could be beneficial. Our study demonstrated that the prognostic scoring model based on exosomal mRNA was highly effective. The six genes selected using the scoring model have been previously reported to be associated with the occurrence and development of liver cancer. However, this study is the first to confirm that these related genes existed in the blood exosomes, which could be used for liquid biopsy of patients with liver cancer, thereby avoiding the need for puncture diagnosis. This approach has a high value in clinical application. Through single-cell sequencing, we found that the six genes in the risk model originate from multiple cell types. This finding suggests that the exosomal characteristic molecules secreted by different types of cells in the microenvironment of liver cancer may serve as diagnostic markers.Keywords
Funding Information
- Shanghai Sailing Program (21YF1457100)
- the National High Technology Research and Development Program of China (2018YFA0108301)
- Peak Disciplines (Type IV) of Institutions of Higher Learning in Shanghai
- Shanghai Key Laboratory of Cell Engineering (14DZ2272300)
- National Natural Science Foundation of China (31971109)
This publication has 41 references indexed in Scilit:
- Serum exosomal microRNA‑122 and microRNA‑21 as predictive biomarkers in transarterial chemoembolization‑treated hepatocellular carcinoma patientsOncology Letters, 2018
- HBx-induced S100A9 in NF-κB dependent manner promotes growth and metastasis of hepatocellular carcinoma cellsCell Death & Disease, 2018
- Hepatocellular carcinomaThe Lancet, 2018
- Exosomes in Cancer Liquid Biopsy: A Focus on Breast CancerMolecular Therapy Nucleic Acids, 2018
- The prognostic value of CYP2C subfamily genes in hepatocellular carcinomaCancer Medicine, 2018
- Prognostic implication of NQO1 overexpression in hepatocellular carcinomaHuman Pathology, 2017
- The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinomaJournal of Cellular and Molecular Medicine, 2017
- S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathwaysExperimental Cell Research, 2015
- Expression of Serum Exosomal MicroRNA-21 in Human Hepatocellular CarcinomaBioMed Research International, 2014
- Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivityBlood, 2005